Connect with us

AI Insights

Commercialization of medical artificial intelligence technologies: challenges and opportunities

Published

on


  • Bajwa, J., Munir, U., Nori, A. & Williams, B. Artificial intelligence in healthcare: transforming the practice of medicine. Future Health. J. 8, e188–e194 (2021).


    Google Scholar
     

  • Lareyre, F. & Raffort, J. Artificial intelligence in vascular diseases: from clinical practice to medical research and education. Angiology https://doi.org/10.1177/00033197251324630 (2025).

  • Song, P. et al. The global and regional prevalence of abdominal aortic aneurysms: a systematic review and modeling analysis. Ann. Surg. 277, 912–919 (2023).

    PubMed 

    Google Scholar
     

  • Eid, M. A. et al. The global burden of peripheral artery disease. J. Vasc. Surg. 77, 1119–1126.e1 (2023).

    PubMed 

    Google Scholar
     

  • Sinha, K., Berczeli, M., Lumsden, A. B. & Roy, T. L. Imaging: new frontiers in vascular training. Methodist Debakey Cardiovasc. J. 18, 39–48 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zaidan, E. & Ibrahim, I. A. AI governance in a complex and rapidly changing regulatory landscape: a global perspective. Humanit. Soc. Sci. Commun. 11, 1121 (2024).


    Google Scholar
     

  • Mastracci, T. M., Anand, S. S. & Aday, A. W. Peripheral artery disease: a high-risk yet understudied, underdiagnosed, and undertreated condition-a call to action. Can. J. Cardiol. 38, 553–554 (2022).

    PubMed 

    Google Scholar
     

  • Chaikof, E. L. et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J. Vasc. Surg. 67, 2–77.e2 (2018).

    PubMed 

    Google Scholar
     

  • Howard, D. P. J. et al. Population‐based study of incidence of acute abdominal aortic aneurysms with projected impact of screening strategy. J. Am. Heart Assoc. 4, e001926 (2015).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dahl, M., Liisberg, M., Stenehjem, M., Al Obeidi, I. & Sanddal Lindholt, J. Screening for abdominal aortic aneurysms still prevents ruptures: a secondary analysis of the VIVA trial. J. Am. Coll. Cardiol. 84, 2494–2496 (2024).

    PubMed 

    Google Scholar
     

  • Anjorin, A. C. et al. Underutilization of guideline-based abdominal aortic aneurysm screening in an Academic Health System. Ann. Vasc. Surg. 83, 184–194 (2022).

    PubMed 

    Google Scholar
     

  • Won, D. et al. Sound the alarm: the sonographer shortage is echoing across healthcare. J. Ultrasound Med. 43, 1289–1301 (2024).

    PubMed 

    Google Scholar
     

  • Chiu, I.-M. et al. Prospective clinical evaluation of deep learning for ultrasonographic screening of abdominal aortic aneurysms. npj Digit. Med. 7, 1–6 (2024).


    Google Scholar
     

  • Viz.ai | AI-Powered Care Coordination. Viz.ai, the Proven AI-Powered Care Coordination Platform https://www.viz.ai/.

  • How Viz.ai hit $48.8M revenue with a 325 person team in 2024. Latka https://getlatka.com/companies/viz.ai.

  • Publications Archive. Viz.ai, the Proven AI-Powered Care Coordination Platform https://www.viz.ai/publications.

  • Pirahanchi, Y. et al. PFO‐ACCESS: Augmenting Communications for Medical Care or Closure in the Evaluation of Patients With Stroke With Cardiac Shunts. Stroke.: Vasc. Interv. Neurol. 5, e001707 (2025).


    Google Scholar
     

  • Colasurdo, M. et al. Estimation of ventricular and intracranial hemorrhage volumes and midline shift on an external validation data set using a convolutional neural network algorithm. Neurosurgery https://doi.org/10.1227/neu.0000000000003455 (2022).

  • Figurelle, M. E. et al. Viz.ai implementation of stroke augmented intelligence and communications platform to improve indicators and outcomes for a comprehensive stroke center and network. AJNR Am. J. Neuroradiol. 44, 47–53 (2023).

    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Karamchandani, R. R. et al. Automated detection of intracranial large vessel occlusions using Viz.ai software: Experience in a large, integrated stroke network. Brain Behav. 13, e2808 (2023).

    PubMed 

    Google Scholar
     

  • Viz.ai Strengthens Information Security with ISO-27001:2022 Certification. Viz.ai, the Proven AI-Powered Care Coordination Platform https://www.viz.ai/news/viz-ai-strengthens-information-security-with-iso-certification.

  • van Leeuwen, K. G. et al. Cost-effectiveness of artificial intelligence aided vessel occlusion detection in acute stroke: an early health technology assessment. Insights Imaging 12, 133 (2021).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Viz.ai revenue, valuation & growth rate. https://sacra.com/c/viz-ai/.

  • FDA approves stroke-detecting AI software. Nat. Biotechnol. 36, 290–290 (2018).

  • Hassan, A. E. New technology add-on payment (NTAP) for Viz LVO: a win for stroke care. J. Neurointerv. Surg. 13, 406–408 (2021).

    PubMed 

    Google Scholar
     

  • Chen, M. M., Golding, L. P. & Nicola, G. N. Who will pay for AI? Radiol. Artif. Intell. 3, e210030 (2021).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Parikh, R. B. & Helmchen, L. A. Paying for artificial intelligence in medicine. NPJ Digit. Med. 5, 63 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Abràmoff, M. D. et al. A reimbursement framework for artificial intelligence in healthcare. NPJ Digit. Med. 5, 72 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • US Food & Drug Administration. Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices (2025).

  • Muralidharan, V. et al. A scoping review of reporting gaps in FDA-approved AI medical devices. npj Digit. Med. 7, 1–9 (2024).


    Google Scholar
     

  • Wu, K. et al. Characterizing the clinical adoption of medical AI devices through U.S. Insurance Claims. NEJM AI 1, AIoa2300030 (2024).


    Google Scholar
     

  • Thomas, R. & Chalkidou, K. Cost–effectiveness analysis. In Health system efficiency: How to make measurement matter for policy and management [Internet] (European Observatory on Health Systems and Policies, 2016).

  • Li, X., Zhao, G., Zhang, J., Duan, Z. & Xin, S. Prevalence and trends of the abdominal aortic aneurysms epidemic in general population–a meta-analysis. PLoS ONE 8, e81260 (2013).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Monaco, L. et al. The complexity of funding rare disease research: an IRDiRC assessment of the landscape. rdodj 3, 27 (2024).


    Google Scholar
     

  • Vervoort, D. et al. One-time screening for abdominal aortic aneurysm in Ontario, Canada: a model-based cost-utility analysis. Can. Med. Assoc. J. 196, E112–E120 (2024).


    Google Scholar
     

  • National Academies of Sciences, E., Division, H. and M., Health, B. on G. & States, C. on G. H. and the F. of the U. Promoting Cardiovascular Health and Preventing Cancer. in Global Health and the Future Role of the United States (National Academies Press (US), 2017).

  • Nishimiya, K., Matsumoto, Y. & Shimokawa, H. Recent advances in vascular imaging. Arterioscler. Thromb. Vasc. Biol. 40, e313–e321 (2020).

    CAS 
    PubMed 

    Google Scholar
     

  • Trowman, R., Migliore, A. & Ollendorf, D. A. The value and impact of health technology assessment: discussions and recommendations from the 2023 Health Technology Assessment International Global Policy Forum. Int. J. Technol. Assess. Health Care 39, e75 (2023).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • US Food & Drug Administration. Good Machine Learning Practice for Medical Device Development: Guiding Principles (2025).

  • Lottes, A. E. et al. Navigating the regulatory pathway for medical devices—a conversation with the FDA, clinicians, researchers, and industry experts. J. Cardiovasc. Transl. Res. 15, 927–943 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Office of the Commissioner (2025) U.S. Food and Drug Administration. FDA https://www.fda.gov/.

  • Dhruva, S. S., Darrow, J. J., Kesselheim, A. S. & Redberg, R. F. Experts’ views on FDA regulatory standards for drug and high-risk medical devices: implications for patient care. J. Gen. Intern. Med. 37, 4176–4182 (2022).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jhawar, N. et al. Impact of professional society guideline publications in medicine subspecialties from 2012 to 2022: implications for clinical care and health policy. Mayo Clin. Proc. Innov. Qual. Outcomes 7, 262–266 (2023).

    PubMed 
    PubMed Central 

    Google Scholar
     

  • US Preventive Services Task Force. et al. Screening for abdominal aortic aneurysm: US Preventive Services Task Force Recommendation Statement. J. Am. Med. Assoc. 322, 2211–2218 (2019).


    Google Scholar
     

  • Ahmed, M. I. et al. A systematic review of the barriers to the implementation of artificial intelligence in healthcare. Cureus 15, e46454 (2023).

    PubMed 
    PubMed Central 

    Google Scholar
     



  • Source link

    AI Insights

    A Neural-Network-Based Approach to Smarter DPD Engines – Electronic Design

    Published

    on



    A Neural-Network-Based Approach to Smarter DPD Engines  Electronic Design



    Source link

    Continue Reading

    AI Insights

    Albania appoints AI bot ‘minister’ to fight corruption in world first | Corruption News

    Published

    on


    Sceptics wonder whether ‘Diella’, depicted as a woman in traditional folk costume, will herself be ‘corrupted’.

    Albanian Prime Minister Edi Rama has put an artificial intelligence-generated “minister” in charge of tackling corruption in his new cabinet.

    Diella, which means “sun” in Albanian, was appointed on Thursday, with the leader introducing her as a “member of the cabinet who is not present physically” who will ensure that “public tenders will be 100 percent free of corruption”.

    Recommended Stories

    list of 3 itemsend of list

    The awarding of tenders has long been a source of corruption in the Balkan country of 2.8 million people, which aspires to join the European Union.

    Corruption is a key factor in Albania’s bid to join the bloc.

    Rama’s Socialist Party, which recently secured a fourth term in office, has said it can deliver EU membership for Albania in five years, with negotiations concluding by 2027.

    Lawmakers will soon vote on Rama’s new cabinet, but it was unclear whether he would ask for a vote on Diella’s virtual post.

    Legal experts say more work may be needed to establish the official status of Diella, who is depicted on screen as a woman in a traditional Albanian folk costume.

    Gazmend Bardhi, parliamentary group leader of the Democrats, said he considered Diella’s ministerial status unconstitutional.

    “[The] Prime Minister’s buffoonery cannot be turned into legal acts of the Albanian state,” Bardhi posted on Facebook.

    The prime minister did not provide details of what human oversight there might be for Diella, or address risks that someone could manipulate the artificial intelligence bot.

    Launched earlier this year as a virtual assistant on the e-Albania public service platform, Diella helped users navigate the site and get access to about one million digital documents.

    So far, she has helped issue 36,600 digital documents and provided nearly 1,000 services through the platform, according to official figures.

    Not everyone is convinced.

    One Facebook user said, “Even Diella will be corrupted in Albania.”

    Another said, “Stealing will continue and Diella will be blamed.”



    Source link

    Continue Reading

    AI Insights

    The AI Ascension: How Artificial Intelligence is Reshaping the 2025 Global Market Landscape – FinancialContent

    Published

    on



    The AI Ascension: How Artificial Intelligence is Reshaping the 2025 Global Market Landscape  FinancialContent



    Source link

    Continue Reading

    Trending